These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27680204)

  • 1. Editorial: (Thematic Issue) Novel Concepts on the Blood-Brain Barrier and Brain Pathology. New Therapeutic Approaches.
    Sharma HS; Skaper SD; Sharma A
    CNS Neurol Disord Drug Targets; 2016; 15(9):1014-1015. PubMed ID: 27680204
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood-brain barrier: recent developments and clinical correlations.
    Benarroch EE
    Neurology; 2012 Apr; 78(16):1268-76. PubMed ID: 22508848
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases.
    Ceña V; Játiva P
    Nanomedicine (Lond); 2018 Jul; 13(13):1513-1516. PubMed ID: 29998779
    [No Abstract]   [Full Text] [Related]  

  • 4. The blood-brain barrier.
    Daneman R; Prat A
    Cold Spring Harb Perspect Biol; 2015 Jan; 7(1):a020412. PubMed ID: 25561720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the blood-brain barrier in Creutzfeldt-Jakob-Heidenhain-Nevin disease].
    Capon A; Flament J; Guazzi GC
    Acta Neuropathol; 1967; ():Suppl 3:47-53. PubMed ID: 6074649
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure and function of the blood-brain barrier.
    Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
    Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of disease: the blood-brain barrier.
    Neuwelt EA
    Neurosurgery; 2004 Jan; 54(1):131-40; discussion 141-2. PubMed ID: 14683550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood-brain barrier in health and disease: Important unanswered questions.
    Profaci CP; Munji RN; Pulido RS; Daneman R
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 32211826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-related deaths are largely due to brain damage.
    Sharma HS
    Indian J Med Res; 2005 May; 121(5):621-3. PubMed ID: 15937362
    [No Abstract]   [Full Text] [Related]  

  • 10. Determinants of passive drug entry into the central nervous system.
    Habgood MD; Begley DJ; Abbott NJ
    Cell Mol Neurobiol; 2000 Apr; 20(2):231-53. PubMed ID: 10696512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blood-brain barrier and its role in inflammation.
    Webb AA; Muir GD
    J Vet Intern Med; 2000; 14(4):399-411. PubMed ID: 10935890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and the blood-brain barrier.
    Lassmann H
    Brain Pathol; 1991 Jan; 1(2):88. PubMed ID: 1669700
    [No Abstract]   [Full Text] [Related]  

  • 13. The plasminogen activation system in neuroinflammation.
    Mehra A; Ali C; Parcq J; Vivien D; Docagne F
    Biochim Biophys Acta; 2016 Mar; 1862(3):395-402. PubMed ID: 26493446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
    Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
    Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of central nervous system manifestations of systemic lupus erythematosus.
    Zvaifler NJ; Bluestein HG
    Arthritis Rheum; 1982 Jul; 25(7):862-6. PubMed ID: 7104058
    [No Abstract]   [Full Text] [Related]  

  • 16. The blood brain barrier in relation to viruses.
    Mosley JW
    JAMA; 1967 Sep; 201(10):769. PubMed ID: 6071887
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy.
    Hartz AM; Bauer B
    Mol Interv; 2010 Oct; 10(5):293-304. PubMed ID: 21045243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of glioma cells on a new co-culture in vitro blood-brain barrier model for characterization and validation of permeability.
    Mendes B; Marques C; Carvalho I; Costa P; Martins S; Ferreira D; Sarmento B
    Int J Pharm; 2015 Jul; 490(1-2):94-101. PubMed ID: 25981617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody therapies in CNS diseases.
    Freskgård PO; Urich E
    Neuropharmacology; 2017 Jul; 120():38-55. PubMed ID: 26972827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of P32 for clinical studies of the permeability of the blood-brain barrier].
    Leksin EN
    Med Radiol (Mosk); 1967 May; 12(5):47-50. PubMed ID: 5621326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.